F1000Research · 2021 · 13 citations · 15 references
Veterinary MedicineClinical SciencesInfectious DiseasesCell TherapyInflammationRegenerative MedicineAcute Lung InjuryInflammatory SignalingMesenchymal Stem Cell TherapyMesenchymal Stromal Cell TherapyPulmonary InflammationRespiratory DiseaseAnti-inflammatory MechanismsCovid-19-associated Acute Respiratory Distress SyndromeCytokine Storm SyndromeCytokine-mediated Lung InjuryMesenchymal Stromal Cell SecretomeSars-cov-2 InfectionSars-cov-2 PneumoniaSevere Acute Respiratory Syndrome
<ns3:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the outbreak of coronavirus disease 2019 (COVID-19), which has been rapidly spreading. Several guideline therapies have been proposed as a possible treatment for SARS-CoV-2, however, these therapies are not sufficient to treat a severe condition of SARS-CoV-2 infection characterised by the increase of D-dimer and C-reactive protein (CRP) levels, and patchy ground-glass opacities (GGOs). Secretome-mesenchymal stem cells (S-MSCs) produced by MSCs under hypoxia could excessively release several anti-inflammatory cytokines and growth factors to control the COVID-19 cytokine storm and accelerate lung injury improvement. This is the first study investigating the clinical outcomes of three severe COVID-19 patients admitted to the intensive care unit of three different hospitals in Indonesia treated with S-MSCs. The decrease of D-dimer and CRP level was reported for all patients treated with S-MSCs. This was in line with improvement of pulmonary radiology, blood gas level, and hematologic assessment. In conclusion, these cases suggest that S-MSCs could effectively control D-dimer, CRP level and GGOs of severe COVID-19 patients associated with recovered pulmonary function.</ns3:p>
15
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Xiaobo Yang, Yu Yuan, Jiqian Xu et al. · The Lancet Respiratory Medicine · 2020 · 10.7K citations · Full text
Anup Agarwal, Aparna Mukherjee, Pranab Chatterjee et al. · BMJ · 2020 · 733 citations · Full text